Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-10-09FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) by Covis Pharma US, Inc, indicating an approved update to the la…
-
FDA approval · 2012-10-05FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2012-09-28FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (lansoprazole) from Takeda Pharmaceuticals America, expanding its labeling and indicati…
-
FDA approval · 2012-09-28FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-09-28FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Prevacid Solutab (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2012-09-28FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add an intravenous formulation of pantoprazole (PROTONIX I.V.) from Wyeth Pharmaceuticals (Pf…
-
FDA approval · 2012-09-28FDA Approved: PANTOPRAZOLE SODIUM — Original Application (NorthStar Rx LLC)
FDA approves Pantoprazole sodium from NorthStar Rx LLC as an Original Application (ANDA), making a generic proton pump inhibitor available f…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Do Acid Sensing Ion Channels Contribute to Heartburn? [Phase 1]
A Phase 1 trial completed to investigate whether acid-sensing ion channels contribute to heartburn in patients with gastroesophageal reflux …
-
FDA approval · 2012-09-18FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved Riley Consumer Care LLC's supplemental application for ZEGERID OTC, a fixed-dose combination of omeprazole and sodium bicar…
-
FDA approval · 2012-09-13FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application to make PRILOSEC OTC (omeprazole magnesium) available as an over-the-counter product for appropr…
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
-
CLINICAL_TRIALS research · 2012-09-12Clinical Trial Update: Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients [NA]
The trial evaluated gastric secretion using MRI while participants were on proton pump inhibitors, including healthy volunteers and individu…
-
FDA approval · 2012-09-10FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for GOOD NEIGHBOR PHARMACY OMEPRAZOLE (omeprazole) under NDA 022032, with Amerisource Bergen as the …
-
FDA approval · 2012-09-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., completing regulatory action for …
-
FDA approval · 2012-09-07FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Pantoprazole sodium from Mylan Pharmaceuticals Inc., continuing approval for this generic produc…
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy [NA]
A clinical trial evaluating reflux disease in head and neck cancer patients undergoing radiation therapy was withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of Lansoprazole in Patients With Reflux Disease [Phase 4]
Phase 4 clinical trial update evaluating the safety and efficacy of Lansoprazole for gastroesophageal reflux disease; results posted after c…
-
FDA approval · 2012-08-27FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
FDA approved a supplemental application for Omeprazole Magnesium by Gericare Pharmaceuticals under ANDA078878, approving the changes describ…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux [Phase 4]
Phase 4 trial evaluating the safety and efficacy of lansoprazole 30 mg twice daily for laryngitis associated with gastroesophageal reflux. T…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux [NA]
A completed clinical trial update examines whether patients who have undergone surgery for achalasia experience reflux.
-
CLINICAL_TRIALS research · 2012-08-15Clinical Trial Update: Assessing Outcomes After Surgery for Gastroesophageal Reflux Disorder [NA]
Clinical trial update from the University of South Florida on outcomes after surgery for Gastroesophageal reflux disease. Phase information …
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects [Phase 2]
This completed Phase 2 pharmacodynamic study evaluated a single dose of AZD2516 in healthy male subjects, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Esomeprazole (NEXIUM) vs. Surgery [Phase 3]
Phase 3 trial comparing esomeprazole (Nexium) with surgery for gastroesophageal reflux disease completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms [Phase 2]
A Phase 2 randomized trial comparing VECAM 40/300 given at bedtime to esomeprazole 20 mg given before dinner, assessing daytime and nighttim…